Schizophrenia is a serious and disabling mental illness whose etiology is not yet clear and for which there are many pathogenesis hypotheses. However, many schizophrenic disorders can be cured clinically after systematic psychiatric treatment, and the prevention or reduction of relapse depends on the regular use of Western antipsychotic drugs to maintain treatment. Modern medicine mostly advocates that schizophrenia should be maintained for at least 3 years after the first episode is clinically cured, at least 5 years after the second episode is clinically cured, and more than three episodes should be treated with lifelong medication. Adherence to maintenance antipsychotic treatment in accordance with strict expert recommendations is essential for future patient recovery. From clinical studies, it is true that some patients who have been clinically cured of their first and second episodes after more than 3-5 years of maintenance antipsychotic Western medicine treatment as prescribed, still have some patients who are no longer relapsing after discontinuing the medicine under the guidance of their doctors. At least statistically, this is true for about 10% of patients. This is a little bit of research result, which still gives hope to many patients. Cognitive behavioral psychotherapy and training in psychiatric rehabilitation techniques are effective adjunctive treatments that have a research basis for improving medication adherence and reducing relapse rates.